Related Experiment Video
Updated: Oct 2, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Pediatric pulmonary veno-occlusive disease associated with a novel BMPR2 variant
Wataru Takemori1, Kenichiro Yamamura1,2, Yoshitaka Tomita1
1Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Insights
Pulmonary veno-occlusive disease (PVOD) and idiopathic/heritable pulmonary arterial hypertension (I/HPAH) share genetic links. A pediatric case with a BMPR2 variant highlights PVOD and I/HPAH as a spectrum of pulmonary vascular disease.
Area of Science:
- Cardiovascular Sciences
- Genetics
- Pediatric Pulmonology
Background:
- Pulmonary veno-occlusive disease (PVOD) and idiopathic/heritable pulmonary arterial hypertension (I/HPAH) are severe forms of pulmonary hypertension (PH) with distinct genetic underpinnings.
- A pediatric case of severe PH, initially refractory to treatment and presenting with hypoxemia and ground-glass opacities, was diagnosed as PVOD.
Discussion:
- The patient developed pulmonary edema following prostaglandin I2 administration, a known complication in PVOD.
- Pathological examination of the explanted lung revealed characteristic PVOD findings: intimal thickening and luminal narrowing of pulmonary veins.
- Genetic analysis identified a novel BMPR2 splice acceptor variant (c.77-2A>C), a mutation typically associated with I/HPAH.
Key Insights:
- This case represents the first pediatric instance of PVOD associated with a BMPR2 variant.
- The findings challenge the strict classification of PVOD and I/HPAH, suggesting they exist on a continuum of pulmonary vascular disease.
- The BMPR2 gene, implicated in I/HPAH, may also play a role in the pathogenesis of PVOD.
Outlook:
- Further research into the genetic landscape of PVOD is warranted to understand the role of BMPR2 and other genes.
- This case underscores the importance of genetic testing in diagnosing complex pediatric PH cases.
- Expanding the understanding of the PVOD and I/HPAH spectrum may lead to improved diagnostic strategies and targeted therapies for pediatric PH.
Abstract:
Pulmonary veno-occlusive disease (PVOD) and idiopathic/heritable pulmonary arterial hypertension (I/HPAH) cause progressive PH on the distinct genetic impact. A 29-month-old boy presented with a loss of consciousness. He had severe PH refractory to pulmonary vasodilators. Hypoxemia and ground-glass opacity on the chest computed tomography were present, and significant pulmonary edema developed after the introduction of continuous intravenous prostaglandin I2 . Based on the clinical diagnosis of PVOD, he underwent a single living-donor lobar lung transplantation with the right lower lobe of his mother. The pathological findings of his explanted lung showed intimal thickening and luminal narrowing of the pulmonary vein. A genetic test revealed a novel heterozygous splice acceptor variant (c.77-2A>C) in BMPR2, which is typically associated with I/HPAH. This is the first pediatric case of PVOD with BMPR2 variant, supporting the concept that I/HPAH and PVOD are part of a spectrum of pulmonary vascular disease.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Other Pulmonary Disorders
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

